Clinical Trials
6 trialsNCT03475589 2020-05-12
Study on the Adverse Drug Reactions (ADRs) of Apatinib and Their Biomarker Correlations
Sun Yat-sen University
Phase 4 Unknown
NCT04133337 2019-10-21
Apatinib Combined With SHR-1210 Injection in the Treatment of Patients With Removable IB-IIIA NSCLC
Sichuan Cancer Hospital and Research Institute
Phase 1/2 Unknown
NCT03889626 2019-03-26
The Maintenance Treatment of Apatinib/Capecitabine Versus Observation in Advanced Gastric Cancer
Fudan University
Phase 3 Unknown
NCT03389256 2018-01-03
Apatinib in the Treatment of Patients With EGFR T790M-Negative NSCLC
Sichuan Cancer Hospital and Research Institute
Phase 2 Unknown
NCT03199677 2017-07-02
A Clinical Study of Apatinib in Patients With Local Progressive/Metastatic Refractory Thyroid Cancer
ChineseAMS
Phase 2 Unknown
NCT00633490 2008-07-22
Study of Apatinib as an Inhibitor of Tumor Angiogenesis
Fudan University
Phase 1 Unknown